Literature review: potential non-thermal molecular effects of external radiofrequency electromagnetic fields on cancer.

Radiofrequency cancer electromagnetic fields hyperthermia therapy

Journal

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
ISSN: 1464-5157
Titre abrégé: Int J Hyperthermia
Pays: England
ID NLM: 8508395

Informations de publication

Date de publication:
2024
Historique:
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 17 7 2024
Statut: ppublish

Résumé

There is an ongoing scientific discussion, that anti-cancer effects induced by radiofrequency (RF)-hyperthermia might not be solely attributable to subsequent temperature elevations at the tumor site but also to non-temperature-induced effects. The exact molecular mechanisms behind said potential non-thermal RF effects remain largely elusive, however, limiting their therapeutical targetability. Therefore, we aim to provide an overview of the current literature on potential non-temperature-induced molecular effects within cancer cells in response to RF-electromagnetic fields (RF-EMF). This literature review was conducted following the PRISMA guidelines. For this purpose, a MeSH-term-defined literature search on MEDLINE (PubMed) and Scopus (Elsevier) was conducted on March 23 Analysis of the data processed in this review suggests that RF-EMF radiation of various frequencies seems to be able to induce significant non-temperature-induced anti-cancer effects. These effects span from mitotic arrest and growth inhibition to cancer cell death in the form of autophagy and apoptosis and appear to be mostly exclusive to cancer cells. Several cellular mechanisms were identified through which RF-EMF radiation potentially imposes its anti-cancer effects. Among those, by reviewing the included publications, we identified RF-EMF-induced ion channel activation, altered gene expression, altered membrane potentials, membrane oscillations, and blebbing, as well as changes in cytoskeletal structure and cell morphology. The existent literature points toward a yet untapped therapeutic potential of RF-EMF treatment, which might aid in damaging cancer cells through bio-electrical and electro-mechanical molecular mechanisms while minimizing adverse effects on healthy tissue cells. Further research is imperative to definitively confirm non-thermal EMF effects as well as to determine optimal cancer-type-specific RF-EMF frequencies, field intensities, and exposure intervals.

Identifiants

pubmed: 39019469
doi: 10.1080/02656736.2024.2379992
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2379992

Auteurs

Anna Dieper (A)

Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Stephan Scheidegger (S)

Institute for Applied Mathematics and Physics, Zurich University of Applied Sciences, Winterthur, Switzerland.

Rudolf M Füchslin (RM)

Institute for Applied Mathematics and Physics, Zurich University of Applied Sciences, Winterthur, Switzerland.
Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Centrum (MDC), Berlin, Germany.

Paraskevi D Veltsista (PD)

Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Ulrike Stein (U)

Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Centrum (MDC), Berlin, Germany.

Mathias Weyland (M)

Institute for Applied Mathematics and Physics, Zurich University of Applied Sciences, Winterthur, Switzerland.

Dominik Gerster (D)

Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Marcus Beck (M)

Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Olof Bengtsson (O)

Ferdinand-Braun-Institut (FBH), Leibnitz-Institut für Höchstfrequenztechnik, Berlin, Germany.

Daniel Zips (D)

Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Pirus Ghadjar (P)

Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH